LGR5 regulates pro-survival MEK/ERK and proliferative Wnt/β-catenin signalling in neuroblastomaGabriella Cunha Vieira, Karim Malik|Oncotarget|2015Cited by 81
The small molecule inhibitor YK-4-279 disrupts mitotic progression of neuroblastoma cells, overcomes drug resistance and synergizes with inhibitors of mitosisMadhu Kollareddy, Karim Malik|Cancer Letters|2017Cited by 40
Spliceosomal vulnerability of MYCN-amplified neuroblastoma is contingent on PRMT5-mediated regulation of epitranscriptomic and metabolomic pathwaysJodie Bojko, Karim Malik|Cancer Letters|2024Cited by 5